The expansion across COEX Halls C, E, and The Platz reflects the surging interest in Korea’s pharmaceutical, biopharma, and nutraceutical sectors. Industry leaders and government bodies, including the Ministry of Food and Drug Safety and the Korea Drug Research Association, are backing the event to bolster cross-border collaborations and leverage the nation's advanced CDMO infrastructure.
In section Releases
CPHI/ Hi Korea 2026 Expands Footprint Amid Rising Global Pharma Demand
With exhibition space growing by 14 percent, CPHI/ Hi Korea 2026 has opened pre-registration for its upcoming event at Seoul’s COEX from August 25 to 27. The gathering anticipates 12,000 industry professionals and 420 companies from more than 70 countries, marking the largest edition in the event’s history.
Building on previous attendance, the conference program has grown to six tracks. Sessions will dive into technical innovations such as ADC, TPD, and RPT, alongside updates on GLP-1 developments and personalized health functional food regulations. Beyond technical discourse, the event serves as a launchpad for startups, offering IR sessions and a Global Build-Up Program designed to facilitate market entry into the United States, Japan, China, Thailand, and Malaysia. With Hall E nearly at capacity, organizers are urging remaining companies to finalize booth applications as the deadline approaches.
Comments (0)
No comments yet. Be the first!